Retrospective review of lung cancer patients with pleural dissemination after limited operations combined with parietal pleurectomy

被引:26
作者
Ohta, Y [1 ]
Shimizu, Y [1 ]
Matsumoto, I [1 ]
Tamura, M [1 ]
Oda, M [1 ]
Watanabe, G [1 ]
机构
[1] Kanazawa Univ, Sch Med, Dept Gen & Cardiothorac Surg, Kanazawa, Ishikawa 9208641, Japan
关键词
lung cancer; carcinomatous pleuritis; malignant effusion; pleurectomy;
D O I
10.1002/jso.20333
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: The long-term control of malignant effusion is necessary to achieve long-term survival in lung cancer patients with carcinomatous pleuritis. This report describes our results of limited operations including parietal pleurectomy (pl) on a hypothesis that the most effective target area for controlling malignant pleural effusion is the parietal pleura. Methods: Forty-two patients with pleural dissemination with/without malignant pleural effusion were analyzed retrospectively. The operative procedures used were partial resection of the primary site with pl in 20 cases, segmentectomy with pl in 2 cases, lobectomy with pl in 19 cases, and pl only in 1 case. Postoperative adjuvant treatment was performed in 31 patients. Results: Adenocarcinoma was the dominant histology, and the pathological stages were IIIB in 34 cases and IV (intrapulmonary metastasis) in 8 cases. The overall 3-, 5-, and 10-year survival rates were 30.1%, 17.2%, and 10.3%, respectively. When stratified by the TNM classification, the overall 3-, 5-, and 10-year survival rates were 56.3%, 32.1%, and 24.1%, respectively, in the T4N0M0 group and 21.1%, 7.0%, and 0%, respectively, in the T4N1-2MO group (P = 0.0257). Among the 24 patients whose recurrent patterns could be identified, only 2 patients developed recurrent malignant effusion. Conclusions: With appropriate patient selection, the use of limited surgery combined with pl followed by intrapleural and systemic chemotherapy appears to be effective in management of the disease.
引用
收藏
页码:237 / 242
页数:6
相关论文
共 23 条
[1]   Early and late mortality after pleurodesis for malignant pleural effusion [J].
Bernard, A ;
de Dompsure, RB ;
Hagry, O ;
Favre, JP .
ANNALS OF THORACIC SURGERY, 2002, 74 (01) :213-217
[2]  
FRANK A, 2000, LUNG CANC PRINCILES, P1027
[3]   EARLY EXPERIENCE WITH VIDEOTHORACOSCOPIC HYDRODISSECTION PLEURECTOMY IN THE TREATMENT OF MALIGNANT PLEURAL EFFUSION [J].
HARVEY, JC ;
ERDMAN, CB ;
BEATTIE, EJ .
JOURNAL OF SURGICAL ONCOLOGY, 1995, 59 (04) :243-245
[4]   PLEURECTOMY IN TREATMENT OF PLEURAL EFFUSION DUE TO METASTATIC MALIGNANCY [J].
JENSIK, R ;
BEATTIE, EJ ;
PERLIA, C ;
KOFMAN, S ;
TAYLOR, S ;
MILLOY, F ;
CAGLE, JE .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1963, 46 (03) :322-&
[5]  
KELLER SM, 1993, CHEST, V103, P63
[6]  
LUH KT, 1992, CANCER-AM CANCER SOC, V69, P674
[7]  
MARTINI N, 1975, CANCER, V35, P734, DOI 10.1002/1097-0142(197503)35:3<734::AID-CNCR2820350328>3.0.CO
[8]  
2-N
[9]   Revisions in the International System for Staging Lung Cancer [J].
Mountain, CF .
CHEST, 1997, 111 (06) :1710-1717
[10]  
NAHID P, 2003, TXB PLEURAL DIS, P35